Table 1.
Distribution of SNPs of interest.
| Homozygous Minor |
Heterozygous | Homozygous Major |
Total | |
|---|---|---|---|---|
| KIBRA | ||||
| rs17070145 (minor: T) | 16 (11.9%) | 62 (44.3%) | 56 (41.8) | N = 134 |
| rs10475878 (minor: A) | 7 (5.2%) | 58 (43.0%) | 70 (51.9%) | N = 135 |
| rs4320284 (minor: G) | 18 (13.4%) | 71 (53.0%) | 45 (33.6%) | N = 134 |
| rs11740112 (minor: G) | 22 (17.7%) | 60 (48.4%) | 42 (33.9%) | N = 124 |
| rs244904 (minor: A) | 26 (19.0%) | 77 (56.2%) | 34 (24.8%) | N = 137 |
| rs10040267 (minor: A) | 28 (20.9%) | 57 (42.5%) | 49 (36.6%) | N = 134 |
| rs13171394 (minor: G) | 35 (25.9%) | 60 (44.4%) | 40 (29.6%) | N = 135 |
| rs6555802 (minor: A) | 14 (10.1%) | 64 (46.0%) | 61 (43.9%) | N = 139 |
| rs2241368 (minor: A) | 29 (21.3%) | 33 (24.3%) | 74 (54.4%) | N = 136 |
| rs1477306 (minor: A) | 16 (11.9%) | 60 (44.4%) | 59 (43.7%) | N = 135 |
| rs7700355 (minor: T) | 0 (0.0%) | 36 (27.5%) | 95 (72.5%) | N = 131 |
| rs11750709 (minor: A) | 12 (8.6%) | 71 (51.1%) | 56 (40.3%) | N = 139 |
| rs1422422 (minor: A) | 10 (7.8%) | 65 (50.8%) | 53 (41.4%) | N = 128 |
| rs4976592 (minor: T) | 9 (6.7%) | 62 (45.9%) | 64 (47.4%) | N = 135 |
| rs3822660 (minor: A) | 0 (0.0%) | 27 (20.6%) | 104 (79.4%) | N = 131 |
| rs3822659 (minor: C) | 0 (0.0%) | 42 (30.2%) | 97 (69.8%) | N = 139 |
| rs1030182 (minor: A) | 24 (17.6%) | 66 (48.5%) | 46 (33.8%) | N = 136 |
| rs7723533 (minor: A) | 8 (5.8%) | 50 (36.0%) | 81 (58.3%) | N = 139 |
| rs6555791 (minor: T) | 14 (10.1%) | 68 (49.3%) | 56 (40.6%) | N = 138 |
| rs11134509 (minor: A) | 14 (10.1%) | 68 (49.3%) | 56 (40.6%) | N = 138 |
| rs764221 (minor: A)* | 15 (11.3%) | 84 (63.9%) | 33 (24.8%) | N = 133 |
| COMT | ||||
| rs4646316 (minor: T) | 6 (4.4%) | 65 (48.1%) | 64 (47.4%) | N = 135 |
| rs1544325 (minor: A) | 14 (10.8%) | 76 (58.5%) | 40 (30.8%) | N = 130 |
| rs4680 (minor: A) | 32 (27.6%) | 50 (43.1%) | 34 (29.3%) | N = 116 |
| rs4633 (minor: T) | 37 (27.2%) | 56 (41.2%) | 43 (31.6%) | N = 136 |
| rs737865 (minor: C) | 13 (9.4%) | 64 (46.4%) | 61 (44.2%) | N = 138 |
| APOE | ||||
| rs429385 & rs7412 (minor: ε4) | 3 (2.4%) | 33 (27.9%) | 101 (69.7%) | N = 122 |
| rs157580 (minor: G) | 15 (12.5%) | 59 (49.2%) | 46 (38.3%) | N = 120 |
| rs439401 (minor: T) | 19 (15.3%) | 53 (42.7%) | 52 (41.9%) | N = 124 |
| rs405697 (minor: T) | 6 (4.4%) | 54 (39.4%) | 77 (56.2%) | N = 137 |
| rs157582 (minor: A) | 13 (9.4%) | 57 (41.3%) | 68 (49.3%) | N = 138 |
| rs405509 (minor: C) | 34 (25.2%) | 61 (45.2%) | 40 (29.6%) | N = 135 |
| rs8106922 (minor: G) | 18 (13.2%) | 66 (48.5%) | 52 (38.2%) | N = 136 |
| BDNF | ||||
| rs1491850 (minor: C) | 23 (16.5%) | 74 (53.2%) | 42 (30.2%) | N = 139 |
| rs985205 (minor: A) | 1 (0.8%) | 44 (36.4%) | 76 (62.8%) | N = 121 |
| rs11030096 (minor: C) | 28 (20.9%) | 69 (51.5%) | 37 (27.6%) | N = 134 |
| rs6265 (minor: A) | 7 (6.7%) | 25 (24.0%) | 72 (69.2%) | N = 104 |
| SORL1 | ||||
| rs668387 (minor: A) | 24 (17.8%) | 78 (57.8%) | 33 (24.4%) | N = 135 |
| rs1131497 (minor: G)* | 19 (14.6%) | 13 (10.0%) | 98 (75.4%) | N = 130 |
| rs1614735 (minor: G) | 31 (23.3%) | 61 (45.9%) | 41 (30.8%) | N = 133 |
| rs2282649 (minor: T) | 11 (10.6%) | 46 (44.2%) | 47 (45.2%) | N = 104 |
| rs1010159 (minor: G) | 21 (15.6%) | 61 (45.2%) | 53 (39.3%) | N = 135 |
| rs689021 (minor: T)* | 19 (14.1%) | 87 (64.4%) | 29 (21.5%) | N = 135 |
| rs641120 (minor: T) | 23 (17.6%) | 72 (55.0%) | 36 (27.5%) | N = 131 |
| rs1699102 (minor: C) | 19 (13.7%) | 72 (51.8%) | 48 (34.5%) | N = 139 |
| rs3824968 (minor: A) | 16 (11.8%) | 61 (44.9%) | 59 (43.4%) | N = 136 |
Note.
*
denotes SNPs that were not in Hardy-Weinberg equilibrium. These SNPs were removed from subsequent analysis.